Test Price
2,800 AED✅ Home Collection Available
CEBPA Germline Mutation Genetic Test for AML in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل الطفرة الجينية CEBPA (الخط الجنسي) لسرطان الدم النخاعي الحاد في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي
Next‑Generation Sequencing – ISO 9001:2015 Certified Laboratory – 3‑4 Weeks TAT – DHA License 9834453
Executive Summary
- 99.9% Diagnostic Sensitivity – ISO 9001:2015 accredited NGS analysis ensuring clinical-grade accuracy for CEBPA germline mutation detection.
- Hospital‑Grade Home Collection – ISO‑certified cold‑chain logistics and VIP mobile phlebotomy (8 AM‑11 PM) included in the 2,800 AED price.
- Post‑Test Clinical Guidance – Telephonic result interpretation by DHA‑licensed geneticists, linking molecular findings to your family pedigree.
- Direct Insurance Billing Verification via WhatsApp at +971 54 548 8731 before collection.
ملخص تنفيذي
- دقة تشخيصية 99.9% – تحليل NGS معتمد وفق ISO 9001:2015 لتحديد الطفرة الجينية CEBPA.
- خدمة سحب منزلي عالية الجودة – نقل مبرد معتمد وخدمة سحب دم متنقلة متميزة طوال اليوم.
- استشارة طبية بعد الفحص – تفسير النتائج من أطباء معتمدين من هيئة الصحة بدبي و ربطها بشجرة العائلة.
- تحقق مباشر من التغطية التأمينية عبر الواتساب: +971 54 548 8731.
Overview
The CEBPA germline NGS test identifies inherited mutations in the CEBPA gene that predispose to familial acute myeloid leukemia (AML). This comprehensive assay screens the entire coding region for all pathogenic variants, enabling risk assessment, early surveillance, and personalised family planning. يفحص هذا الاختبار الجيني الطفرات الموروثة في جين CEBPA المرتبطة بسرطان الدم النخاعي الحاد العائلي.
| Feature | Our NGS Test | Sanger Sequencing / Single‑Gene Assay |
|---|---|---|
| Diagnostic Sensitivity | 99.9% (full coding region, all variant types) | ~95% (limited to selected exons) |
| Methodology | Next‑Generation Sequencing (NGS) | Sanger sequencing or targeted PCR |
| Turn‑Around Time | 3‑4 Weeks | 4‑6 Weeks |
| Regulatory Compliance | DHA Accredited, ISO 9001:2015, UAE PDPL | Variable |
Physician Insight & Safety Protocol
“As a DHA‑licensed physician, I emphasize that a positive CEBPA germline result does not equate to a leukemia diagnosis; it reveals inherited susceptibility. All results must be interpreted alongside a full clinical history and family pedigree, and shared with your treating oncologist or hematologist for preventive strategies. Do not discontinue any prescribed medication without direct consultation.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
Safety Exclusions & Urgent Red Flags
- Exclusion Criteria: Patients who have received allogeneic hematopoietic stem cell transplant within the past 3 months (donor DNA interference). Active severe sepsis or haemodynamic instability at the time of collection.
- Genetic Counselling Mandatory: UAE Federal Decree-Law No. 41 of 2024 (Art. 87) and CDS Law 2026 require pre‑test genetic counselling, which we provide. Minors must have parental consent per CDS 2026.
- Emergency Symptoms – Seek Immediate Medical Attention: If the patient develops new acute bleeding, sudden high fever >38.5°C, severe weakness, or petechiae, do not wait for test results – go to the nearest Emergency Department. This test is not for acute leukaemia management.
- Data Privacy: Your genomic data are protected under UAE PDPL; shared only with authorised healthcare professionals.
Frequently Asked Questions
What does the CEBPA germline test detect?
Snippet: Our NGS test detects inherited CEBPA mutations linked to familial AML with 99.9% diagnostic sensitivity.
It identifies germline (inherited) mutations in the entire CEBPA gene, which significantly increase the lifetime risk of developing acute myeloid leukemia. A positive result guides personalised surveillance and family screening.
يكتشف تحليلنا الطفرات الموروثة في جين CEBPA المرتبطة بسرطان الدم النخاعي الحاد العائلي بحساسية 99.9%.
Why is genetic counselling required before testing?
Snippet: Genetic counselling ensures accurate pedigree analysis and informed consent before testing for inherited CEBPA mutations.
A certified genetic counsellor will review your family history, explain potential outcomes, and support you in understanding the implications for yourself and your relatives. This step is mandated by UAE law (Federal Decree-Law No. 41/2024).
تضمن الاستشارة الوراثية تحليل شجرة العائلة بدقة والحصول على الموافقة المستنيرة قبل فحص طفرات CEBPA الموروثة.
What is the turn‑around time for results?
Snippet: Your CEBPA germline mutation results are reported within 3 to 4 weeks from sample collection.
The laboratory completes sequencing, bioinformatics analysis, and clinical reporting in 21‑28 calendar days. A preliminary verbal update may be available after 2 weeks for urgent cases.
تُصدر نتائج تحليل طفرة CEBPA الجينية خلال 3 إلى 4 أسابيع من جمع العينة.
Pre‑ Preparation
- Provide detailed clinical history and family pedigree (if available).
- A mandatory genetic counselling session will be arranged to draw a detailed family pedigree chart.
- Sample types accepted: Whole blood (3‑5 mL in EDTA tube), extracted DNA (>1 µg), or one drop of blood on an FTA card.
- No fasting required. Continue regular medications unless otherwise directed by your physician.
- For whole blood, avoid samples clotted or haemolysed; inform us if you have received a blood transfusion in the past 2 weeks.
DHA Licensed Facility: 9834453 | ISO 9001:2015 Cert: INT/EGQ/2509DA/3139 | UAE Federal Decree-Law No. 41 of 2024 | CDS Law 2026 | UAE PDPL Compliant
Home collection available daily 8 AM – 11 PM. WhatsApp: +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians